
    
      A total of 60 participants will be enrolled consisting of healthy adults (18-45 years) and
      infants (5-17 months) residing in Bagamoyo district, Tanzania. Participants will be recruited
      from areas of low malaria transmission in Bagamoyo town and areas of high malaria
      transmission within Bagamoyo district. All participants will be followed for 2-2.5years after
      the first vaccination with RH5.1/Matrix-M vaccination. The duration of the entire study will
      be 2-2.5years per participant from the time of first vaccination.
    
  